Description

The Edwards Lifesciences Surgical Valve portfolio defines the benchmark in cardiac surgery, combining advanced biomaterial science, anatomical design, and engineering precision to reproduce the natural function of the human heart.

Each model in the line is designed for a specific surgical indication:

• INSPIRIS RESILIA (aortic): a next-generation bioprosthetic valve incorporating RESILIA™ anti-calcification tissue technology, ensuring long-term durability and flexibility. Its innovative design enables Valve-in-Valve compatibility, making it suitable for future minimally invasive reinterventions.
• MITRIS RESILIA (mitral): engineered for mitral position, maintaining the native annular geometry and enabling physiological blood flow. The RESILIA™ tissue ensures enhanced structural preservation under the high-pressure mitral environment.
• KONECT RESILIA: the first preassembled valved conduit combining a RESILIA™ aortic valve with a Dacron graft, offering a ready-to-implant solution for complex aortic root or Bentall procedures, reducing operative time and simplifying reconstruction.
• Magna Ease Aortic: clinically proven valve with a low-profile design, providing excellent hemodynamics and easy surgical handling. Its flexible sewing ring and symmetrical design ensure accurate coaptation and low pressure gradients.
• Magna Ease Mitral: optimized for mitral position, this model ensures smooth leaflet motion, durable coaptation, and physiological valve function in degenerative or post-repair cases.
• Intuity Elite System: a rapid-deployment aortic valve system combining a pericardial Magna Ease valve with an expandable frame for minimal manipulation and reduced bypass time. It allows stable fixation and is ideal for minimally invasive approaches.

Combining exceptional biocompatibility, outstanding flow dynamics, and surgical efficiency, Edwards Lifesciences Surgical Valves deliver reliable long-term outcomes and adaptability to evolving cardiac care strategies.